Varilrix® is used for primary vaccination of infants from nine months of age, children and adults to protect against varicella-zoster infection (chickenpox). The vaccine may prevent or reduce the severity of chickenpox disease if it is given within 3-5 days of exposure to someone with the disease.
Varilrix® is temporarily out of stock. Additional information is available in the GSK notification issued May 2013 Varilrix temporarily out of stock.
